Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing

被引:65
作者
Overhoff, Kirk A.
Moreno, Alejandro
Miller, Dave A.
Johnston, Keith P.
Williams, Robert O., III
机构
[1] Univ Texas, Coll Pharm, Austin, TX 78712 USA
[2] Univ Texas, Dept Chem Engn, Austin, TX 78712 USA
关键词
particle engineering; amorphous; supersaturation; nanoparticle; enteric polymer; dissolution model;
D O I
10.1016/j.ijpharm.2006.11.043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The primary objective of the study is to investigate the influence of composition parameters including drug:polymer ratio and polymer type, and particle structure of enteric solid dispersions on the release of ITZ under sink and supersaturated dissolution conditions. Modulated differential scanning calorimetry (MDSC) was utilized to define the level of ITZ miscibility with each polymer. The compositions were completely miscible at 60% ITZ for both polymers and as high as 70% in HP-55. High potency composition glass transition temperatures (Tg) correlated with predicted Tg's from the Gordon-Taylor equation, however, recrystallization exotherms revealed pure amorphous regions indicating that phase separation occurred during particle formation. Furthermore, in vitro studies including X-ray powder diffraction (XRD), scanning electron microscopy (SEM), surface area analysis (BET), and dissolution were performed to determine differences between low potency (completely miscible) and high potency (partially miscible) compositions. Dissolution studies on low potency ITZ compositions revealed that miscibility plays an active role in ITZ release under sink conditions, and square root diffusion through the enteric polymer is observed. Supersaturated dissolution profiles revealed high potency compositions had maximum saturation levels (C/C-eqmax) between 10.6- and 8-times equilibrium solubility, but had higher cumulative extents of supersaturation, compared to low potency compositions which had C/C-eqmax values of 15-19.6. However, these low potency compositions rapidly precipitated leading to significantly lower AUCs (p < 0.05). The change in the miscibility of the solid dispersion had a pronounced effect of drug release (sink) while differences in potency influenced supersaturated dissolution profiles. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:122 / 132
页数:11
相关论文
共 36 条
[21]   Micronized powders of a poorly water soluble drug produced by a spray-freezing into liquid-emulsion process [J].
Rogers, TL ;
Overhoff, KA ;
Shah, P ;
Santiago, P ;
Yacaman, MJ ;
Johnston, KP ;
Williams, RO .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 55 (02) :161-172
[22]  
Rowe RaymondC., 2003, Handbook of Pharmaceutical Excipients
[23]  
SATO T, 1981, CHEM PHARM BULL, V29, P2675
[24]   Physical stability and enthalpy relaxation of drug-hydroxypropyl methylcellulose phthalate solvent change co-precipitates [J].
Sertsou, G ;
Butler, J ;
Hempenstall, J ;
Rades, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (01) :35-41
[25]  
SHERWOOD L, 2004, HUMAN PHSYL CELLS SY
[26]   Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution [J].
Sinswat, P ;
Gao, XX ;
Yacaman, MJ ;
Williams, RO ;
Johnston, KP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 302 (1-2) :113-124
[27]   Identification of phase separation in solid dispersions of itraconazole and Eudragit® E100 using microthermal analysis [J].
Six, K ;
Murphy, J ;
Weuts, I ;
Craig, DQM ;
Verreck, G ;
Peeters, J ;
Brewster, M ;
Van den Mooter, G .
PHARMACEUTICAL RESEARCH, 2003, 20 (01) :135-138
[28]   Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers [J].
Six, K ;
Verreck, G ;
Peeters, J ;
Brewster, M ;
Van den Mooter, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (01) :124-131
[29]   Thermal properties of hot-stage extrudates of itraconazole and eudragit E100 - Phase separation and polymorphism [J].
Six, K ;
Leuner, C ;
Dressman, J ;
Verreck, G ;
Peeters, J ;
Blaton, N ;
Augustijns, P ;
Kinget, R ;
Van den Mooter, G .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2002, 68 (02) :591-601
[30]   Modification of crystal growth mechanism of yttrium oxalate in metastable solution [J].
Sung, MH ;
Kim, JS ;
Kim, WS ;
Hirasawa, I ;
Kim, WS .
JOURNAL OF CRYSTAL GROWTH, 2002, 235 (1-4) :529-540